Sidorova-Darmos E, Fallah M, Logan R, Lin C, Eubanks J
Front Physiol. 2022; 13:948387.
PMID: 36148309
PMC: 9489219.
DOI: 10.3389/fphys.2022.948387.
Cortes M, Corder K, Dobrunz L
Stress. 2021; 24(6):965-977.
PMID: 34546150
PMC: 8908778.
DOI: 10.1080/10253890.2021.1976139.
Tucker L, Winston B, Liu J, Velosky A, Fu A, Grillakis A
PLoS One. 2019; 14(9):e0222153.
PMID: 31487322
PMC: 6728068.
DOI: 10.1371/journal.pone.0222153.
Higgs J, Wasowski C, Marcos A, Jukic M, Pavan C, Gobec S
Heliyon. 2019; 5(3):e01376.
PMID: 30949609
PMC: 6430037.
DOI: 10.1016/j.heliyon.2019.e01376.
Corder K, Cortes M, Bartley A, Lear S, Lubin F, Dobrunz L
PLoS One. 2018; 13(7):e0200809.
PMID: 30024942
PMC: 6053188.
DOI: 10.1371/journal.pone.0200809.
Neuropsychiatric Symptom Modeling in Male and Female C57BL/6J Mice after Experimental Traumatic Brain Injury.
Tucker L, Burke J, Fu A, McCabe J
J Neurotrauma. 2016; 34(4):890-905.
PMID: 27149139
PMC: 5314988.
DOI: 10.1089/neu.2016.4508.
Preclinical animal anxiety research - flaws and prejudices.
Ennaceur A, Chazot P
Pharmacol Res Perspect. 2016; 4(2):e00223.
PMID: 27069634
PMC: 4804324.
DOI: 10.1002/prp2.223.
Inter-individual diversity and intra-individual stability of amphetamine-induced sensitization of frequency-modulated 50-kHz vocalization in Sprague-Dawley rats.
Taracha E, Hamed A, Krzascik P, Lehner M, Skorzewska A, Plaznik A
Psychopharmacology (Berl). 2012; 222(4):619-32.
PMID: 22354555
PMC: 3402670.
DOI: 10.1007/s00213-012-2658-4.
Role of nitric oxide in amphetamine-induced sensitization of schedule-induced polydipsic rats.
Liu Y, Tung C, Lin P, Wan F
Psychopharmacology (Berl). 2011; 218(3):599-608.
PMID: 21625906
DOI: 10.1007/s00213-011-2354-9.
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.
Sink K, Segovia K, Sink J, Randall P, Collins L, Correa M
Eur Neuropsychopharmacol. 2009; 20(2):112-22.
PMID: 20015619
PMC: 2817975.
DOI: 10.1016/j.euroneuro.2009.11.002.
Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils.
Heldt S, Davis M, Ratti E, Corsi M, Trist D, Ressler K
Behav Pharmacol. 2009; 20(7):584-95.
PMID: 19675456
PMC: 2946835.
DOI: 10.1097/FBP.0b013e32832ec594.
Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.
He J, Kong J, Tan Q, Li X
Cell Adh Migr. 2009; 3(1):129-37.
PMID: 19372744
PMC: 2675159.
DOI: 10.4161/cam.3.1.7401.
Dissociating anxiolytic and sedative effects of GABAAergic drugs using temperature and locomotor responses to acute stress.
Vinkers C, Klanker M, Groenink L, Korte S, Cook J, van Linn M
Psychopharmacology (Berl). 2009; 204(2):299-311.
PMID: 19169673
PMC: 2752628.
DOI: 10.1007/s00213-009-1460-4.
Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest.
Roy V, Chapillon P, Jeljeli M, Caston J, Belzung C
Psychopharmacology (Berl). 2008; 203(1):131-41.
PMID: 18998112
DOI: 10.1007/s00213-008-1378-2.
Persistent downregulation of hippocampal CREB mRNA parallels a Y-maze deficit in adolescent rats following semi-chronic amphetamine administration.
Featherby T, van den Buuse M, Lubman D, Lawrence A
Br J Pharmacol. 2008; 154(2):417-28.
PMID: 18475255
PMC: 2442450.
DOI: 10.1038/bjp.2008.126.
Localized injections of midazolam into the amygdala and hippocampus induce differential changes in anxiolytic-like motor activity in mice.
Heldt S, Ressler K
Behav Pharmacol. 2006; 17(4):349-56.
PMID: 16914953
PMC: 2525667.
DOI: 10.1097/01.fbp.0000224386.86615.e0.
Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats.
Hirani K, Sharma A, Jain N, Ugale R, Chopde C
Psychopharmacology (Berl). 2005; 180(2):267-78.
PMID: 15719223
DOI: 10.1007/s00213-005-2169-7.
Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors.
Atack J, Hutson P, Collinson N, Marshall G, Bentley G, Moyes C
Br J Pharmacol. 2005; 144(3):357-66.
PMID: 15655523
PMC: 1576012.
DOI: 10.1038/sj.bjp.0706056.
Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice.
Kliethermes C, Finn D, Crabbe J
Psychopharmacology (Berl). 2003; 169(2):190-7.
PMID: 12783153
DOI: 10.1007/s00213-003-1493-z.
Agonizing over antagonizing: what do benzodiazepine receptor antagonists demonstrate?.
Sarter M, Berntson G, Bruno J, Givens B
Psychopharmacology (Berl). 1996; 126(2):182-4.
PMID: 8856839
DOI: 10.1007/BF02246355.